Werewolf Therapeutics (HOWL) Return on Assets (2021 - 2026)
Werewolf Therapeutics (HOWL) posted quarterly Return on Assets of 0.01% for Q2 2026, little changed year-over-year from 0.01% in Q2 2025, and up 9.65% on a QoQ basis from 0.01% in Q1 2026.
Werewolf Therapeutics (HOWL) Return on Assets (2021 - 2026) Analysis & Trends
Werewolf Therapeutics has reported Return on Assets for 6 years, with the latest figure at 0.01% in Q2 2026.
- Return on Assets for Q2 2026 came in at 0.01%, changed 0.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.01%, down 1.0% from the prior year.
- Return on Assets climbed to 0.01% in Q2 2026, from 0.01% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q3 2023 and troughed at 0.01% in Q1 2026.
- A 5-year average of 0.01% and a median of 0.0% in 2022 frame the typical range for Return on Assets.
- The largest YoY upside for Return on Assets was 0 bps in 2022 against a maximum downside of 0 bps in 2022.
- A 5-year view of Return on Assets shows it stood at 0.0% in 2022, then soared by 37 bps to 0.0% in 2023, then tumbled by 155 bps to 0.01% in 2024, then sank by 63 bps to 0.01% in 2025, then grew by 1 bps to 0.01% in 2026.
- Per Business Quant data, the three most recent Return on Assets figures were 0.01% in Q2 2026, 0.01% in Q1 2026, and 0.01% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.00% |
| 10 | Werewolf Therapeutics | 43.00 Mn | 43.00 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |